Evidence map›Paper›PMID 36251275›Full record

ArticleGigaScience2022

High temporal resolution Nanopore sequencing dataset of SARS-CoV-2 and host cell RNAs.

Dóra Tombácz, Ákos Dörmő, Gábor Gulyás, Zsolt Csabai, István Prazsák, Balázs Kakuk, Ákos Harangozó, István Jankovics, Béla Dénes, Zsolt Boldogkői

Open access · goldAbstract read
In one paragraph

Article in GigaScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Dóra TombáczDepartment of Medical Biology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged 6720, Hungary.ORCID 0000-0001-5520-2978
Ákos DörmőDepartment of Medical Biology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged 6720, Hungary.ORCID 0000-0003-1860-1122
Gábor GulyásDepartment of Medical Biology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged 6720, Hungary.ORCID 0000-0002-7465-7932
Zsolt CsabaiDepartment of Medical Biology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged 6720, Hungary.ORCID 0000-0003-0031-0116
István PrazsákDepartment of Medical Biology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged 6720, Hungary.ORCID 0000-0003-3195-503X
Balázs KakukDepartment of Medical Biology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged 6720, Hungary.ORCID 0000-0002-4314-5707
Ákos HarangozóDepartment of Medical Biology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged 6720, Hungary.ORCID 0000-0001-8499-8485
István JankovicsComplex Medical Center, Budapest 1012, Hungary.ORCID 0000-0001-5329-9294
Béla DénesVeterinary Diagnostic Directorate, National Food Chain Safety Office, Budapest 1143, Hungary.ORCID 0000-0002-9889-529X
Zsolt BoldogkőiDepartment of Medical Biology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged 6720, Hungary.ORCID 0000-0003-1184-7293
University of Szeged · HUICAR Research Complex for NEH Region · INNational Food Chain Safety Office · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent studies have disclosed the genome, transcriptome, and epigenetic compositions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the effect of viral infection on gene expression of the host cells. It has been demonstrated that, besides the major canonical transcripts, the viral genome also codes for noncanonical RNA molecules. While the structural characterizations have revealed a detailed transcriptomic architecture of the virus, the kinetic studies provided poor and often misleading results on the dynamics of both the viral and host transcripts due to the low temporal resolution of the infection event and the low virus/cell ratio (multiplicity of infection [MOI] = 0.1) applied for the infection. It has never been tested whether the alteration in the host gene expressions is caused by aging of the cells or by the viral infection.

findingsIn this study, we used Oxford Nanopore's direct cDNA and direct RNA sequencing methods for the generation of a high-coverage, high temporal resolution transcriptomic dataset of SARS-CoV-2 and of the primate host cells, using a high infection titer (MOI = 5). Sixteen sampling time points ranging from 1 to 96 hours with a varying time resolution and 3 biological replicates were used in the experiment. In addition, for each infected sample, corresponding noninfected samples were employed. The raw reads were mapped to the viral and to the host reference genomes, resulting in 49,661,499 mapped reads (54,62 Gbs). The genome of the viral isolate was also sequenced and phylogenetically classified.

conclusionsThis dataset can serve as a valuable resource for profiling the SARS-CoV-2 transcriptome dynamics, the virus-host interactions, and the RNA base modifications. Comparison of expression profiles of the host gene in the virally infected and in noninfected cells at different time points allows making a distinction between the effect of the aging of cells in culture and the viral infection. These data can provide useful information for potential novel gene annotations and can also be used for studying the currently available bioinformatics pipelines.

Indexed as

COVID-19Nanopore SequencingAnimalsDNA, ComplementaryKineticsRNASARS-CoV-2DNA, ComplementaryRNAcoronavirusdirect cDNA sequencingdirect RNA sequencingfull-length transcriptomelong-read sequencingMinION systemOxford Nanopore TechnologiesSARS-CoV-2

Identifiers

PMID36251275
PMCPMC9575581
OpenAlexW4306668129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.